De Marchi, Elena
Orioli, Elisa
Pegoraro, Anna
Sangaletti, Sabina
Portararo, Paola
Curti, Antonio
Colombo, Mario Paolo
Di Virgilio, Francesco http://orcid.org/0000-0003-3566-1362
Adinolfi, Elena http://orcid.org/0000-0001-8129-9929
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (IG 16812)
Article History
Received: 29 August 2018
Revised: 6 December 2018
Accepted: 23 December 2018
First Online: 17 January 2019
Compliance with ethical standards
:
: Professor FDV is a member of the Scientific Advisory Board of Biosceptre Ltd, a Biotech Company involved in the development of P2X7-targeted therapies. The remaining authors declare that they have no conflict of interest.